Market news
TypeAll
SortNewest
Assets
CRVS
Corvus Pharmaceuticals Announces Publication in Blood of Final Phase 1 Data from the Soquelitinib Phase 1/1b T Cell Lymphoma Trial
Data supports ongoing registration Phase 3 trial in r/r PTCL, Phase 2 trial in atopic dermatitis and planned trials for hidradenitis suppurativa and...
Aug 27Barchart.com
CRVS
This is the newest page. Registered accounts read further back.